Sumeru Pharma Limited - Due diligence report

A 360° intelligence report on Sumeru Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

2010-11-26 Hyderabad, Telangana Active Unlisted Active Non-Compliant
Share
SP Sumeru Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sumeru Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
60/100
Trust Score
Moderate

Sumeru Pharma Limited is assessed as Moderate with a Trust Score of 60/100. Sumeru Pharma Limited is an active public limited indian non-government company incorporated in 2010, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Sumeru Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
60/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (1.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank1 48.0 cr
Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
DEVINENI RAHUL CHOWDARY 01234567 Director 01/04/2018 6 yrs Approved
KUCHIPUDI RAMAJOGESWARA RAO 01234567 Director 01/04/2018 6 yrs Approved
DEVINENI PADMAJA 01234567 Director 01/04/2018 6 yrs Approved
DEVINENI SAI SAHUL 01234567 Director 01/04/2018 6 yrs Approved
DEVINENI VENKATESWARA RAO 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • DEVINENI RAHUL CHOWDARY has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: DEVINENI PADMAJA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 65
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 15+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (25/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence48/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 1.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
23 Mar 2015
Director ceased
DEVINENI PADMAJA
31 May 2013
Director ceased
DEVINENI VENKATESWARA RAO
05 Jun 2012
Securities allotted
46500 Equity Shares Without Differential Rights - 4.65 Lakh raised
Securities allotted
280800 Equity Shares Without Differential Rights - 28.08 Lakh raised
30 Mar 2012
Charge created
Canara Bank - 1.00 cr
03 Sep 2011
Securities allotted
540000 Equity Shares Without Differential Rights - 54.00 Lakh raised
28 Jul 2011
Director ceased
DEVINENI RAHUL CHOWDARY
15 Apr 2011
Director appointed
DEVINENI RAHUL CHOWDARY (Director)
26 Nov 2010
Incorporated
Registered with Roc Hyderabad
Director appointed
KUCHIPUDI RAMAJOGESWARA RAO (Director)
Director appointed
DEVINENI PADMAJA (Managing Director)
Director appointed
DEVINENI SAI SAHUL (Director)
Director appointed
DEVINENI VENKATESWARA RAO (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
5 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2015 annual return.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sante Sois Medicaments Private Limited U24233GJ2010PTC059787 Vadodara, Gujarat, India
Garment Care India Private Limited U24243KA2003PTC032163 Bangalore, Karnataka, India
Halmak Pharmaceuticals Private Limited U24230TG1997PTC026415 Na, Telangana, India
Synergy Formulation Private Limited U24231GJ2004PTC043698 Ahmadabad City, Gujarat, India
Atharva Herbals Private Limited U24233MH2002PTC135183 Vasai, Maharashtra, India
Alexa Bio Tech Private Limited U24232CH2009PTC031889 Chandigarh, Chandigarh, India
V S Equipments And Automations Private Limited U28939MH2005PTC153604 Thane, Maharashtra, India
Dacca Oushadhalaya Pvt Ltd U24233WB1948PTC016705 Paschim Midnapore, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sumeru Pharma Limited before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sumeru Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Sumeru Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 60/100, distress signals and MSME payment-delay disclosures - know whether Sumeru Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sumeru Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sumeru Pharma Limited an active company?

Sumeru Pharma Limited has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Sumeru Pharma Limited financially healthy?

Sumeru Pharma Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Sumeru Pharma Limited?

Its overall Trust Score is 60/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sumeru Pharma Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Sumeru Pharma Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Sumeru Pharma Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Sumeru Pharma Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.